Faride Ramos
Internal Medicine · Sunrise, FLNPI 1467721464
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 55 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 21.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $830, 3.9 times the $213 reported in 2019.
Across 55 payments — averaging $60.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cerapedics Inc.$719
- Novo Nordisk$430
- Globus Medical$294
- Amgen$253
- Spinal Simplicity, LLC$245
- Lilly USA, LLC$144
- plus $1K from 19 others
Across 130 payments — averaging $17,661 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$1.5M
- Avanir Pharmaceuticals, Inc.$491K
- Amgen$266K
- Boehringer Ingelheim$849
What the payments were for
- Food & beverage$3,315100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cerapedics Inc. | 6 | $719 |
| Novo Nordisk | 8 | $430 |
| Globus Medical | 2 | $294 |
| Amgen | 9 | $253 |
| Spinal Simplicity, LLC | 1 | $245 |
| Lilly USA, LLC | 3 | $144 |
| Stryker | 1 | $141 |
| Sanofi-aventis U.S. LLC | 2 | $140 |
| Heartflow, Inc. | 1 | $134 |
| Osteomed LLC | 1 | $127 |
| Avanir Pharmaceuticals, Inc. | 1 | $125 |
| Exact Sciences | 3 | $81 |
| Nalu Medical, Inc. | 1 | $81 |
| Medtronic | 1 | $77 |
| Astellas Pharma US Inc | 2 | $64 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $42 |
| Pfizer | 2 | $37 |
| Currax Pharmaceuticals LLC | 2 | $34 |
| TELA Bio, Inc. | 1 | $30 |
| Abbott | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
| Genentech USA, Inc. | 1 | $20 |
| Acella Pharmaceuticals, LLC | 1 | $19 |
| Menarini Silicon Biosystems, Inc. | 1 | $18 |
| Johnson & Johnson | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,315 in reported general payments places this provider in the 85th percentile of 8,530 internal medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 18 | $555 |
| Levothyroxine Sodium | 12 | $57 |
| Amlodipine Besylate | 11 | $24 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Sunrise
- Haytham ElgammalMiami$2.2M
- Keith RubinFort Lauderdale$2M
- Michael SensionFort Lauderdale$1M
- Quang NguyenOcala$434K
- Luis Correa LunaSanford$412K
- Michael OleksykFort Myers$365K
- Andrew KuykendallTampa$322K
- Howard FederoffCoconut Grove$302K
- Bianka EperjesiovaGainesville$260K
- Julio ConradoFort Myers$247K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.